Cargando…
A radiologist’s guide to novel anticancer therapies in the era of precision medicine
Novel anticancer agents have replaced conventional chemotherapy as first line agents for many cancers, with continued new and expanding indications. Small molecule inhibitors act on cell surface or intracellular targets and prevent the downstream signaling that would otherwise permit tumor growth an...
Autores principales: | Khader, Ali, Bokhari, Rozan, Hakimelahi, Reza, Scheirey, Christopher, Afnan, Jalil, Braschi-Amirfarzan, Marta, Thomas, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899228/ https://www.ncbi.nlm.nih.gov/pubmed/35265736 http://dx.doi.org/10.1016/j.ejro.2022.100406 |
Ejemplares similares
-
Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
por: Braschi-Amirfarzan, Marta, et al.
Publicado: (2017) -
Teaching cancer imaging in the era of precision medicine: Looking at the big picture
por: N Chin, Christopher, et al.
Publicado: (2022) -
Extracutaneous melanomas: a primer for the radiologist
por: Keraliya, Abhishek R., et al.
Publicado: (2015) -
Radiology Consultation in the Era of Precision Oncology: A Review of Consultation Models and Services in the Tertiary Setting
por: DiPiro, Pamela J., et al.
Publicado: (2017) -
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine
por: Vernuccio, Federica, et al.
Publicado: (2021)